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Abstract
HSPB1, also classified as heat shock protein 27 (Hsp27), is a small
chaperone that is active in cells during stressful conditions. The chaperone can stabilize
target proteins in a non-aggregated folding state and might be involved in regulation of
folding and assembly of neurofilaments. There are five mutations in the genome of
Hsp27 that are involved in Charcot Marie Tooth Disease (CMT). This
neurodegenerative disease is characterized by the first decades of life where it slowly
progresses to weakness of muscles followed by sensory loss and skeletal deformities.
CMT is the most common hereditary neuromuscular disease, with an estimated rate of
1 in 2500 people in the United States. It is still not clear what role the mutations play in
the mechanism that leads to the disease. Some studies have shown that the mutations
result in an abnormal binding affinity between the mutant and wild-type protein.
This project aims to study the function and structure of the wild-type
Hsp27 compared to one of the mutations S135F. The gene for Hsp27 was cloned
and transformed into BL21(DE3) bacterial cells for protein expression. It was then
purified using anion exchange chromatography followed by size exclusion
chromatography. The chaperone protein activity in the oligomerization state was
assayed by using alpha-lactalbumin aggregated by a reducing agent, dithiothreitol
(DTT) in-vitro. The secondary structure of Hsp27 WT and mutation S135F were
evaluated through the following biophysical analyses: circular dichroism and dynamic
light scattering. The structure of mutation S135F was evaluated under a transmission
electron microscope.

vi

Table of Contents
Acknowledgements ..................................................................................................................... v
Abstract ........................................................................................................................................ vi

Chapter 1: Introduction ..................................................................................................... 1
1.1 The Function and Structure of Proteins ............................................................................. 2
1.1.1 Protein Biosynthesis ................................................................................................. 2
1.1.2 Protein Structure Levels ........................................................................................... 3
1.1.3 Chaperonins and Chaperones ................................................................................. 6
1.1.4 Misfolded Proteins and their effect in Cellular Homeostasis ................................ 9
1.2 The Molecular Chaperone Heat Shock Protein27 ........................................................... 10
1.2.1 Quaternary Structure of Hsp27 .............................................................................. 11
1.2.2 Function of Hsp27 ................................................................................................... 12
1.3 The Role of Hsp27 in Charcot-Marie-Tooth Disease ...................................................... 15

Chapter 2: Methodologies in Structural Biochemistry ................................................18
2.1 DNA Cloning ......................................................................................................................... 19
2.1.1 Amplification of Gene Sequences through Polymerase Chain Reaction .......... 20
2.1.2 The Components of a Plasmid ............................................................................... 22
2.1.3 Bacterial Transformation ........................................................................................ 23
2.2 Protein Expression and Purification ................................................................................. 23
2.2.1 Bacterial Expression of Recombinant Protein ..................................................... 23
2.2.2 Protein Extraction .................................................................................................... 25
2.2.3 Fast Protein Liquid Chromatography .................................................................... 26
2.2.3.1 Ion-exchange Chromatography .......................................................................... 27
2.2.3.2 Size-exclusion Chromatography ......................................................................... 29
2.2.4 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS) ................ 30
2.3 Biophysical Analyses of Proteins ..................................................................................... 31
2.3.1 Circular Dichroism .................................................................................................. 31
2.3.2 Dynamic Light Scattering ....................................................................................... 33
2.4 Electron Microscopy ........................................................................................................... 34
2.4.1 Instrumentation ....................................................................................................... 34
2.4.2 Specimen Preparation for Negative Staining ........................................................ 36

Chapter 3: Experimental Approaches for Hsp27 and point mutation S135F ...........39
3.1 Cloning Heat Shock Protein 27 .......................................................................................... 40
3.2 Optimization of Protein Expression Levels for Soluble Protein................................... 46
3.3 Cell Lysis ............................................................................................................................... 47
3.4 Purification of Hsp27 and mutation S135F ...................................................................... 49
3.5 Chaperone Activity Assay of Hsp27 and S135F ............................................................. 50
3.6 Negative Staining ................................................................................................................. 51
3.6.1 Negative Staining Sample Preparation .................................................................. 51
3.6.2 Negative Staining Data ............................................................................................ 52
3.7 Biophysical Analysis ........................................................................................................... 52
3.7.1 Circular Dichroism (CD) .......................................................................................... 52
3.7.2 Dynamic Light Scattering (DLS) ............................................................................. 53

Chapter 4: Results, Discussion, and Conclusion ........................................................54
4.1 Purity Analyses of Hsp27 WT and S135F ......................................................................... 55

vii

4.2 Chaperone Activity for mutation S135F compared to Hsp27WT ................................. 57
4.3 Secondary Structure of mutation S135F and Hsp27 WT ............................................... 60
4.4 Size Characteristics of Hsp27 WT and S135F Chaperone............................................. 64
4.5 Micrographs of Hsp27 WT and S135F .............................................................................. 66
4.6 Conclusion ............................................................................................................................ 67

Works Cited ........................................................................................................................69
Curriculum Vita ..................................................................................................................75

viii

List of Figures
Figure 1.1 A summary of transcription and translation in eukaryotic cells. Adapted from
Pearson Education, Inc., publishing as Benjamin Cummings (Cummings, n.d.). ...... 3
Figure 1.2 The primary structure consists of a sequence of amino acids linked together
by peptide bonds. The polypeptide can be arranged into units of secondary
structure, such as an alpha helix or beta strand. The units are part of the tertiary
structure, and multiple subunits of itself make up the quaternary structure. Adapted
from Lehninger Principles of Biochemistry, 6th Edition (Nelson & Cox, 2012)............ 4
Figure 1.3 Represents the different interactions of amino acid side chains that contribute
to tertiary structure. Some of the interactions include hydrogen bonding, ionic
bonding, and dipole-dipole interaction. Also, hydrophobic interactions in which
amino acids with nonpolar side chains cluster together in the inside of the protein,
leaving the hydrophilic amino acids on the outside of the protein that can interact
with other molecules. Another interaction are disulfide bonds, that are covalent
linkages between the sulfur containing side chains of cysteines. This interaction is
the strongest interaction that contributes to maintaining the tertiary structure
because it keeps the polypeptide firmly attached together. Adapted from LibreTexts
from bio.libretexts.org (Protein structure , 2017). ........................................................... 6
Figure 1.4 Three kinds of processes that contribute to protein homeostasis. Protein
folding can go through different pathways with the assistance of a chaperones or
chaperonins. With the help of a chaperone (including chaperonins), the protein can
fold into its native conformation. If unfolding occurs, the protein becomes misfolded,
which can aggregate, degrade, or go back to its folding intermediate. Adapted from
Lehninger Principles of Biochemistry, 6th Edition (Nelson & Cox, 2012)..................... 7
Figure 1.5 Represents the role of heat shock proteins and small heat shock protein in
recognition and refolding of unfolded proteins. Heat shock proteins use ATP for
folding proteins to their native conformation. If unfolded protein is not recognized by
the Hsp/sHsp then the unfolded protein can form an aggregate. Adapted from
Wilhelmus et al., 2007 (Wilhelmus, 2007). ...................................................................... 8
Figure 1.6 A summary of the main mechanisms of Hsp27. The primary mechanism is
protein folding, effects on the cytoskeleton, reduction of oxidative stress,
suppression of apoptosis or cell death. Hsp27 presents in various oligomeric states
and is regulated by phosphorylation. Adapted from Vidyasagar et al, 2012
(Vidyasagar, Wilson, & Djamali, 2012). .......................................................................... 14
Figure1.7 CMT causes degeneration of the peripheral nervous system, leading to
muscle weakness in the body’s lower extremities (Charcot-Marie-Tooth Disease
(CMT), 2017). ..................................................................................................................... 15
Figure 2.1 A schematic diagram showing the steps in cloning beginning with digestion of
the vector and DNA through the use of restriction endonucleases, ligating the sticky
or blunt ends of the vector and plasmid, followed by inserting the recombinant
vector to a host cell, where the host cell produces many copies of recombinant
DNA. Adapted from Lehninger Principles of Biochemistry, 6th Edition (Nelson &
Cox, 2012). ......................................................................................................................... 19

ix

Figure 2.2 A schematic diagram of the cycles in the polymerase chain reaction with a
final product showing many copies of the initial gene. Adapted from Giri, 2015 (Giri,
2015). .................................................................................................................................. 21
Figure 2.3 A map section of an expression vector system that contains a selection
marker for antibiotic resistance. A multiple cloning site, an origin of replication that
denotes how many copies are produced depending on the expression vector.
Affinity tags and promoters that are recognized by some polymerases such as T7
polymerase. Adapted from Rosano & Ceccarelli, 2014 (Rosano & Ceccarelli, 2014).
.............................................................................................................................................. 22
Figure 2.4 The regulation of transcription in a host cell for obtaining recombinant protein
using T7 RNA polymerase and IPTG. Adapted from the pET Manual (PET system
manual, n.d.). ..................................................................................................................... 24
Figure 2.5 A schematic diagram of a liquid chromatography system, composed of a
pump, mixer, sample application, a detector, and fraction collector. Adapted from
Introduction to practical biochemistry (6.5 High performance (high pressure) liquid
chromatography (HPLC), n.d.). ....................................................................................... 26
Figure 2.6 Ion exchange column composed of negative charged resin (cation exchange)
bound with positive charged protein. Proteins that are net negatively charged
cannot bind to the resin and are eluted earlier. Adapted from Lehninger Principles
of Biochemistry, 6th Edition (Nelson & Cox, 2012)........................................................ 28
Figure 2.7 Size-exclusion column composed of porous polymer beads. Smaller proteins
enter through these beads whereas proteins that are larger can pass through more
freely, and elute earlier. Adapted from Lehninger Principles of Biochemistry, 6th
Edition (Nelson & Cox, 2012). ......................................................................................... 29
Figure 2.8 Instrumentation for CD spectrometer showing linear polarized light and the
direction of right-handed circular polarized light and left-handed circular polarized
light (A), the spectra showing different signatures of secondary structure (B).
Adapted from Lehninger Principles of Biochemistry, 6th Edition (Nelson & Cox,
2012), and LibreTexts, Circular Dichroism (Circular Dichroism, 2017). .................... 32
Figure 2.9 Represents the analysis of fluctuation of scattering light based on the size of
the particle. Adapted from Otsuka, Principle of particle sizing: Dynamic Light
Scattering Method (Dynamic Light Scattering Spectrophotometer DLS-8000 |
Otsuka Electronics, n.d.). ................................................................................................. 34
Figure 2.10 Set up of a transmission electron microscope (A). The set up of the electron
gun for emission of electrons (B). The electron trajectory in a magnetic field lens
(C). Adapted from the University of Iowa’s Center for Microscopic Analysis
(Transmission Electron Microscopy, n.d.). ..................................................................... 36
Figure 2.11 A schematic of specimen preparation: sample, negative stain composed of
a heavy metal, blotting, and image formation. Adapted from Orlova, 2011 (Orlova,
2011). .................................................................................................................................. 38
Figure 3.1 .7% agarose gel with PCR products of three reactions that were done to add
the mutation S135F. The two PCR products were combined to obtained the final
product with the mutation S135F. Sybr Safe from Invitrogen was used to stain the
DNA and emit fluorescence when placed under blue light. ......................................... 42

x

Figure 3.2 .7% agarose gel that contains the products of the before and after digested
pET vector and S135F. Sybr Safe from Invitrogen was used to stain the DNA that
emit fluorescence when placed under blue light. .......................................................... 43
Figure 3.3 .7% agarose gel shows the colonies that have the DNA sequence S135F.
Meaning that the cells were able to uptake pET22 (b) with HSPB1 mutation. Sybr
Safe from Invitrogen was used to stain the DNA and emit fluorescence when
placed under blue light...................................................................................................... 44
Figure 3.4 10% SDS-PAGE gel for testing protein expression with 1mM IPTG for 1 hour
(A) 10% SDS-PAGE gel for protein expression with 1mM IPTG for 2 hours (B). .... 46
Figure 3.5 10% SDS-PAGE showing the amount of protein that is expressed when
using different concentrations of IPTG over time at a temperature of 30ºC. ............ 47
Figure 3.6 10% SDS-PAGE showing a gradient of ammonium sulfate at different
concentrations to locate at which concentration Hsp27 precipitates. ........................ 49
Figure 4.1 12% SDS-PAGE for concentrated fractions of Hsp27 WT (A) and S135F (B)
after a two-column purification, ion-exchange followed by size-exclusion column. . 56
Figure 4.2 Red line indicates the control where no chaperone is added. Green line
represents chaperone activity for mutation S135F with alpha-lac. Blue line indicates
the chaperone activity of wild-type with alpha-lac (A). 12% SDS-PAGE gel showing
the pellet of the precipitated proteins from the chaperone assay (B). ....................... 58
Figure 4.3 Green line represents the chaperone activity for mutation S135F. Orange line
indicates the chaperone S135F with DTT only. ............................................................ 59
Figure 4.4 Green line represents the secondary structure of S135F at 60µM. Blue line
indicates the secondary structure at 100µM. Brown line indicates secondary
structure at 200 µM (A). Green line shows the secondary structure of Hsp27 WT at
60µM. Blue line indicates the secondary structure at 100µM (B). .............................. 61
Figure 4.5 Blue line is the secondary structure of S135F at 5ºC. Light blue line indicates
at 25ºC. Green line indicates at 37ºC. Red line indicates at 42ºC (A). Blue line is
the secondary structure of Hsp27 WT at 5ºC. Light blue line indicates at 25ºC.
Green line indicates at 37ºC. Read line indicates at 42ºC (B). ................................... 63
Figure 4.6 Blue line indicates the size distribution of Hsp27 WT at 25ºC. Dark grey
indicates the size distribution at 37ºC. Red line indicates the size distribution at
42ºC. Light grey indicates the size distribution at 5ºC. ................................................ 64
Figure 4.7 Red line indicates the size distribution of mutation S135F at 5ºC. Blue line
indicates the size distribution at 25ºC. Black line indicates the size distribution at
37ºC. Green line indicates the size distribution at 42ºC. ............................................. 65
Figure 4.8 Negative stain image of S135F at .1 mg/mL from TEM. ................................... 66

xi

Chapter 1: Introduction

1

1.1 The Function and Structure of Proteins
Protein molecules are vital to any living organism. Proteins are built from a
universal base set of 20 amino acids that are covalently linked together that are able to
interact with each other to guide protein-folding, therefore, influencing function and overall
size (Adams, 2008). The interactions that occur between the different amino acids has to
be precise in order for the protein to maintain its correct function and structure. Improper
folding can lead to a malfunction in the cells which leads to disease. Many studies are
conducted on how function and structure of proteins change when a single amino acid is
altered (i.e. point mutations).
1.1.1 Protein Biosynthesis
Proteins are involved in many roles such as catalyzing reactions, transporting
molecules, and providing structure in order to maintain homeostasis in living organisms
(Adams, 2008). Since proteins are extremely vital to a cell they must be continuously
synthesized. The process begins with DNA replication in the nucleus of a cell, the DNA
product is then transcribed into messenger RNA (mRNA). After transcription, the mRNA
molecule exits the nucleus and moves into the cytoplasm where a ribosome begins to
read the mRNA sequence. The ribosome recognizes three letter combinations known
as codons that code for a certain amino acid. As amino acids are added to the chain of
a growing polypeptide the nascent protein exits the ribosome and the folding process
begins.
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Figure 1.1 A summary of transcription and translation in
eukaryotic cells. Adapted from Pearson Education, Inc.,
publishing as Benjamin Cummings (Cummings, n.d.).
1.1.2 Protein Structure Levels
Linderstrøm-Lang performed many laboratory studies on protein denaturation
and the accessibility of peptide bonds and found that protein structure is highly dynamic
(Schellman & Schellman, 1997). He and Schellman realized that protein structure was
hierarchical and proposed four levels of complexed structural organization: primary,
secondary, tertiary, and quaternary structure (Linderstrøm-Lang & Schellman, 1959)
(Figure 1.2). All four levels that would play an important role in studying the function and
structure of proteins.
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Figure 1.2 The primary structure consists of a sequence of amino acids linked together
by peptide bonds. The polypeptide can be arranged into units of secondary structure,
such as an alpha helix or beta strand. The units are part of the tertiary structure, and
multiple subunits of itself make up the quaternary structure. Adapted from Lehninger
Principles of Biochemistry, 6th Edition (Nelson & Cox, 2012).

The primary structure is a sequence of amino acids linked by peptide bonds that
determines the architecture of how the protein will fold and function. The side chains of
amino acids have different chemistries in terms of charge, polarity, and aromaticity. The
chemistry within the amino acids is critical to protein structure because the unique side
chains interact with one another, forming different kind of interactions (eg. hydrogen and
covalent bonds, ionic and hydrophobic interactions) leading to a certain protein
conformation that will determine how it functions. Therefore, the location of each amino
acid is highly important for determining how a protein will bend and fold.
Secondary structures such as alpha helices and beta sheets are formed by the
interactions of amino acids that from hydrogen bonds between each other. The
secondary structure are hydrogen bonding patterns that give rise to helix and sheet
4

elements that are within a protein. Hydrogen bonding can only occur between hydrogen
and a strong electronegative atom such as fluorine, oxygen, and nitrogen. Pauling and
Corey proposed that these interactions were the building blocks of proteins defined by
hydrogen bonding of close or distant related regions of the polypeptide chain (Pauling &
Corey, 1951). The alpha helix presents itself as a rod-like structure where the inner
section is composed of tightly coiled chains while its side chains are extending outward.
The alpha helical structure is stabilized by hydrogen bonding between the amide
hydrogen and the carbonyl oxygen (Engelking, 2015). The beta strands are composed
of a long range of interactions that form beta sheets (Caetano-Anollés, Wang, CaetanoAnollés, & Mittenthal, 2009) (Engelking, 2015). The sheets can arrange in parallel when
the two chains are aligned in the same direction from the amino group and carboxyl
group or antiparallel sheets when both chains have opposing directions (Engelking,
2015) (Caetano-Anollés, Wang, Caetano-Anollés, & Mittenthal, 2009). There are
different environments where a certain type of pattern may favor or maintain a better
stability for the overall protein structure.
The tertiary structure is the overall three-dimensional structure of a protein. The
folds are involved by using the lowest energy conformations of individual amino acids
and forming a compact structure (Caetano-Anollés, Wang, Caetano-Anollés, &
Mittenthal, 2009). The packing is composed of both alpha helix and beta sheets
together where the side chains interact and maintain the structure (Caetano-Anollés,
Wang, Caetano-Anollés, & Mittenthal, 2009) (Figure 1.3). For some proteins, they are
made up of a single polypeptide chain and only have three levels of structure. However,
other proteins can be made up of separate polypeptide chains that are folded into a
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supramolecular unit known as quaternary structure. Once the protein is fully folded,
structural changes may still arise due to things like changes in the environment,
interaction with other proteins, or modification by other proteins or molecules (eg.
cofactors).

Figure 1.3 Represents the different interactions of amino acid side chains that contribute
to tertiary structure. Some of the interactions include hydrogen bonding, ionic bonding,
and dipole-dipole interaction. Also, hydrophobic interactions in which amino acids with
nonpolar side chains cluster together in the inside of the protein, leaving the hydrophilic
amino acids on the outside of the protein that can interact with other molecules. Another
interaction are disulfide bonds, that are covalent linkages between the sulfur containing
side chains of cysteines. This interaction is the strongest interaction that contributes to
maintaining the tertiary structure because it keeps the polypeptide firmly attached
together. Adapted from LibreTexts from bio.libretexts.org (Protein structure , 2017).
1.1.3 Chaperonins and Chaperones
Unfolded polypeptides can go through different conformations before finalizing to
its final structure or native conformation. However, because the cytoplasm contains many
organelles and a high concentration of proteins, there is a high risk of these proteins that
are in the folding process to interact with other partially folded proteins (Alberts, et al.,
6

2013) (Evstigneeva, Solov'eva, & Sidel'nikova, 2000), This can lead to the misfolding of
the protein and aggregation. Therefore, cells maintain proteostasis (Figure 1.4) by the
use of chaperones and chaperonins that prevent unintended folding patterns that can
occur (Alberts, et al., 2013).

Figure 1.4 Three kinds of processes that contribute to protein homeostasis. Protein
folding can go through different pathways with the assistance of a chaperones or
chaperonins. With the help of a chaperone (including chaperonins), the protein can fold
into its native conformation. If unfolding occurs, the protein becomes misfolded, which can
aggregate, degrade, or go back to its folding intermediate. Adapted from Lehninger
Principles of Biochemistry, 6th Edition (Nelson & Cox, 2012).
A chaperone is a protein that selectively recognizes and binds to proteins exposed
hydrophobic surfaces in a noncovalent interaction in order to inhibit protein aggregation
(Slavotinek & Biesecker, 2001) (Figure 1.5). Chaperones were discovered when there
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was an increase of chaperone activity in cells during stressful conditions such as UV
irradiation, temperature changes, and chemical challenges (Evstigneeva, Solov'eva, &
Sidel'nikova, 2000). Because of this, chaperones are also called heat shock proteins
(Hsp). All known chaperones have similar functions in that that they protect the protein
from an environment that may cause the protein to aggregate.

Figure 1.5 Represents the role of heat shock proteins and small heat shock protein in
recognition and refolding of unfolded proteins. Heat shock proteins use ATP for folding
proteins to their native conformation. If unfolded protein is not recognized by the
Hsp/sHsp then the unfolded protein can form an aggregate. Adapted from Wilhelmus et
al., 2007 (Wilhelmus, 2007).
There are two types of chaperones: the first is classified as monomers of 70-100
kDa, and the second group as chaperonins that have a complex oligomeric structure and
a molecular weight of 800 kDa (Evstigneeva, Solov'eva, & Sidel'nikova, 2000). In the
1980s, Ellis proposed that chaperone protein families that have quaternary structure and
high molecular weights are called chaperonins (Ellis, Phil. Trasn. Biol. Sci., 1993) (Ellis &
Hemmingsen, Trends Biochem. Sci., 1989). The chaperonins are big complexes
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composed of two stacked rings radially arranged subunits with a molecular weight of 60
kDa each (Slavotinek & Biesecker, 2001). These larger complexes are commonly ATPdependent in folding non-native proteins and binding of non-native substrate (Bukau &
Horwich, 1998). Their effective chaperonin activity is regulated by the binding of additional
co-factors or co-chaperones that catalyze the inter-conversion between ATP and ADP
states. When ATP binds to the chaperonin, it releases peptides rapidly, resulting in low
overall affinity, whereas the ADP-bound chaperonin binds peptides slowly but more
stably.
Chaperones, are small heat shock proteins that are ATP-independent, and are
regulated by heat stress. Studies performed in vitro showed that small heat shock proteins
work as molecular chaperones in preventing irreversible thermal denaturation of other
proteins (Vierling, 1997). The hydrophobic surfaces of chaperones serve as the binding
sites for a misfolded protein. This complex formation prevents protein aggregation until
the polypeptide can be folded under favorable conditions (Slavotinek & Biesecker, 2001).
Although the functions of chaperones and chaperonins have a similar principle, there is
evidence that the assembly of a particular protein may be performed by a specific
chaperone or chaperonin (Evstigneeva, Solov'eva, & Sidel'nikova, 2000).
1.1.4 Misfolded Proteins and their effect in Cellular Homeostasis
Proteins that are folded correctly, display specific biological activities whereas
misfolded proteins can become detrimental to the cell (Evstigneeva, Solov'eva, &
Sidel'nikova, 2000). Many neurodegenerative diseases have been linked to the
accumulation of misfolded proteins turning into aggregated protein, or soluble protein
gradually converted to insoluble protein (Selkoe, 2004). As the buildup of these misfolded

9

proteins occurs this progressively compromises the cellular and tissue function, leading
to different diseases (Selkoe, 2004).
Chaperones themselves can also become misfolded due to mutations within their
encoding can gene, physical or chemical changes. This can quickly become problematic
because a misfolded chaperone can no longer aid in the prevention of aggregation of
other misfolded proteins. Chaperones that are deficient because of a structural change,
may result in the formation of defective proteins that are no longer transported to
appropriate subcellular destination, or that exhibit a loss-of-function (Ellis, Proteins as
molecular chaperones, 1987) (Hohn, Hohn, Engel, Wurth, & Smith, 1979) (Hartl, 1996)
(Langer, et al., 1992). This can be seen in many diseases such as Desmin-related
myopathy, Congenital cataracts, and Charcot Marie Tooth (CMT) (Slavotinek &
Biesecker, 2001).
1.2 The Molecular Chaperone Heat Shock Protein27
The gene HSPB1 encodes for the small heat shock protein 27 (Hsp27) that is a
systemically expressed molecular chaperone that can be located in the brain, smooth,
skeletal, and cardiac muscles. Hsp27 is a member of the small heat shock proteins
found in both prokaryotic and eukaryotic cells. Hsp27 is part of the alpha crystallin
family because it shares a conserved 80-100 amino acid sequence (Haslbeck, 2002)
(Fontaine, Rest, Welsh, & Benndorf, 2003). The protein is composed of 205 amino
acids with a molecular mass of 27 kDa as the name implies.
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1.2.1 Quaternary Structure of Hsp27
Many small heat shock proteins share a common architecture arising from the
conserved alpha-crystallin domain (ACD), proposing that this location has an important
role in the assembly of the final structure (Baranova, et al., 2011). Scientific papers
have reported that truncated ACD mediates a dimer formation of individual units that
may assemble the arrangement of small heat shock proteins (Baranova, et al., 2011).
This dimer is formed by the symmetrical antiparallel pairing of two beta-strands (beta7),
generating an extended beta-sheet on one face of the ACD (Baranova, et al., 2011).
However, the ACD fragment in Hsp27 shows hexamers (six structural subunits) by an
asymmetric contact between beta4 and beta7 strands from adjacent ACDs (Baranova,
et al., 2011). A crystal structure, showed a relative weakness of this interface
(beta7/beta7 and beta4/beta7) that can easily dissociate and rearrange (Baranova, et
al., 2011). Therefore, it could easily come apart by a point mutation present in the ACD
which may explain diseases that are caused by structural effects in heat shock proteins.
The structure of ACD seems to be a hotspot for many diseases causing inherited
mutations (Sun & MacRae, 2005), (Laskowska, Matuszewska, & Kuczyńska-Wiśnik,
2010). Six missense mutations located in the ACD of Hsp27 have been linked to type II
form of Charcot-Marie-Tooth neuromuscular disease and distal hereditary neuropathy
(Laskowska, Matuszewska, & Kuczyńska-Wiśnik, 2010) (Dierick, Irobi, De Jonghe, &
Timmerman, 2005). However, the structure of Hsp27 and other small heat shock
proteins remains unknown because they form heterogeneous structures due to the
polydispersity of ACD. Recent crystal structures of the ACD containing fragments from
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several vertebrate sHsp’s reveal a lack of pattern in the dimer interface (Bagnéris, et al.,
2009) (Laganowsky, et al., 2010).
Many have reported that the structure of Hsp27 is yet to be discovered due to the
range of oligomerization states (Mymrikov, Bukach, Seit-Nebi, & Gusev, 2010)
(Almeida-Souza, et al., 2010). The quaternary structure of Hsp27 can form a range of
oligomers, from dimers of an estimated size of 54 kDa, to large complexes of about 800
kDa (Takeuchi, 2006). It is said that there is a dynamic process between the formation
of dimers, tetramers, and oligomers. The oligomers can consist of 16 to 32 subunits that
are exchanged within each other at a high rate (Thériault, et al., 2004), (Ehrnsperger,
Lilie, GaesteI, & Buchner, 1999) (Rogalla, et al.). The complex of Hsp27 is regulated
upon phosphorylation by mitogen-activated protein (MAP)-kinase-dependent
(MAPKAPK2) (Garrido, et al., 1999), which leads to the dissociation of the complex. The
range of subunit exchange and formation of different sizes, gives rise to its unique
functions within the cell.
1.2.2 Function of Hsp27
Hsp27 is upregulated in times of cellular stress and limits the consequences of
cellular damage by increasing cellular recovery rates. In response to environmental,
physical, and chemical changes, Hsp27’s primary function as a chaperone is to
recognize and bind to exposed hydrophobic patches of partially denatured proteins,
preventing them from irreversible aggregation. Many of the charged residues in Hsp27
are critical for chaperone functions, but difficult to identify if specific residues are
involved in substrate binding and loss of chaperone function. The unfolded substrates
are kept in a folding competent state until they can be shuttled to a chaperonin complex
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for refolding or are marked for degradation. Hsp27 can interact with diverse substrates
as a general chaperone preventing the aggregation-prone misfolded proteins from
interacting. Notably, Hsp27 binds to signal transduction proteins with a number of
transcriptional factors and mRNA processing proteins such as mRNA splicing proteins
(Marin-Vinader, Shin, Onnekink, Manley, & Lubsen, 2006) (Fu, 2014). Furthermore,
Hsp27 has different chaperone functions dependent on the substrate and the
oligomerization state (Arrigo & Gibert, 2012) (Katsogiannou, Andreieu, & Rocchi, 2014).
Hsp27 undergoes a concentration-dependent equilibrium dissociation from large
oligomers to a dimer. This phenomenon plays a critical role in the primary function of
Hsp27 as a chaperone that mediates protein folding, enabling high affinity binding to
destabilized client proteins (McDonald, Bortolus, Koteiche, & Mchaourab, 2012).
Hsp27 is not always depended upon for protein folding as it is also involved in
various cellular roles such as control of apoptosis, regulation of actin dynamics, and
protection against oxidative stress (Figure 1.6) (Arrigo, et al., 2005) (Aquilina, Shrestha,
Morris, & Ecroyd, 2013).
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Figure 1.6 A summary of the main mechanisms of Hsp27. The primary
mechanism is protein folding, effects on the cytoskeleton, reduction of
oxidative stress, suppression of apoptosis or cell death. Hsp27 presents in
various oligomeric states and is regulated by phosphorylation. Adapted from
Vidyasagar et al, 2012 (Vidyasagar, Wilson, & Djamali, 2012).
Several investigations revealed that Hsp27 responds to cellular stress conditions
other than heat shock; for example, chemical and oxidative stress. During oxidative
stress, Hsp27 functions as an antioxidant by increasing the levels of glutathione and
decreasing the levels of iron that is essential to reactive oxygen species (ROS)
formation (Vidyasagar, Wilson, & Djamali, 2012) (Arrigo, et al., 2005) (Mehlen, Hickey,
Weber, & Arrigo, 1997). Hsp27 also functions as an anti-apoptotic agent in chemical
stressed environments by interacting with mitochondrial dependent and independent
pathways. Interestingly, the protein can protect the cell from stress-damage-induced
death by inhibition of caspase-dependent apoptosis (Vidyasagar, Wilson, & Djamali,
2012) (Calderwood, Khaleque, Sawyer, & Ciocca, 2006) (Takeuchi, 2006) (Charette,
Lavoie, Lambert, & Landry, 2000) (Charette & Landry, 2000). Previous studies reported
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that high expression levels of Hsp27 can be found in many cancers such as leukemia,
breast cancer, and endometrial cancer (Fuller, et al., 1994) (Ciocca, Oesterreich,
Chamness, McGuire, & Fuqua, 1993). Lastly, Hsp27 has the ability to regulate actin
cytoskeletal dynamic during heat shock and other stress conditions (Benndorf, et al.,
1994) (Huot, Houle, Spitz, & Landry, 1996). The regulation relies on phosphorylated
Hsp27 where it prevents filament degeneration and promotes polymerization (Guay, et
al., 1997) (Huot, Houle, Spitz, & Landry, 1996), whereas unphosphorylated Hsp27 acts
as an actin capping protein (Benndorf, et al., 1994).
1.3 The Role of Hsp27 in Charcot-Marie-Tooth Disease
Charcot-Marie-Tooth (CMT) disease is a disorder that affects the peripheral
nervous system causing weakness and atrophy
of distal limb muscles, depressed or absent
tendon reflexes, and mild to moderate sensory
abnormalities

(Charcot-Marie-Tooth

Disease

Fact Sheet, n.d.). The disease affects 1 in 2500
people in the U.S. CMT is caused by mutations in
genes that produce proteins that are involved in
the structure and function of the peripheral nerve
axon and the myelin sheath (Charcot-MarieTooth Disease Fact Sheet, n.d.) (Charcot-MarieTooth Disease (CMT), 2017). The nerves begin
to degenerate and lose their ability to send Figure1.7 CMT causes degeneration of
the peripheral nervous system, leading to
signals to distant targets. This results in muscle muscle weakness in the body’s lower
extremities (Charcot-Marie-Tooth Disease
(CMT), 2017).
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weakness in the arms, legs, hands, or feet (Figure 1.7). The disease is commonly
inherited in an autosomal dominant fashion, meaning only one copy of the abnormal gene
is needed to cause the disease (Charcot-Marie-Tooth Disease Fact Sheet, n.d.).
There are many forms of CMT such as CMT2 that results from abnormalities in the
axon of the peripheral nerve cell rather than the myelin sheath. There are less common
forms of CMT2 that are associated with gene mutations in genes such as HSPB1, that
encodes for Hsp27. In 2004, it was reported that five point mutations located in small heat
shock protein 27 were linked to CMT and distal hereditary motor neuropathy.
Interestingly, four of the five mutations are located in the alpha-crystallin domain, which
can cause loss of chaperone activity (Muchowski, Wu, Liang, Adman, & Clark, 1999)
(Chung, et al., 2008) (Evgrafov, et al., 2004). Three of these (S135F, R127W, and R136)
mutations lead to an increase, rather than a loss in chaperone activity (Almeida-Souza,
et al., 2011), whereas the other two mutations (T151I and P182L) do not show hyper
activation. This could be due to mutations displaying an increased affinity to their client
proteins (Almeida-Souza, et al., 2011), and therefore failing to release the misfolded
protein.
Hsp27 can stabilize target proteins in a non-aggregated folding-competent state,
and might be involved in the regulation of folding and the assembly of neurofilaments
(Pareyson, Marchesi, & Salsano, 2013). In vivo studies found that mutation S135F in
Hsp27 affects the filament networks by causing aggregates in the assembly of the
neurofilaments leading to premature axonal degeneration (Evgrafov, et al., 2004). As
highlighted, the exact role of each point mutation and whether its primary function in
protein folding is the underlying cause in CMT remains unclear. A complete
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understanding of all cellular processes explaining the pathogenesis and the structures of
all point mutations in Hsp27 remains elusive.
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Chapter 2: Methodologies in Structural Biochemistry
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2.1 DNA Cloning
Molecular cloning is a process where a DNA of interest is introduced into a carrier
DNA known as a plasmid that is transported into a host where many copies of
recombinant DNA are reproduced (Nelson & Cox, 2012). There are several procedures
involved in restriction enzyme cloning
which was the cloning method used in
this work (Figure 2.1): Cutting the target
DNA at precise locations by using
restriction endonucleases, selecting a
cloning vector for delivery of the gene
into the cells, joining the vector and the
DNA through DNA ligase, moving the
recombinant DNA to a host cell for
reproduction, and finally identifying host
cells that contain the DNA (Nelson &
Cox, 2012). There are a variety of host
cells that can be used to obtain
recombinant protein, but here we focus
on DNA cloning in Escherichia coli (E.
coli).
Figure 2.1 A schematic diagram showing the steps in cloning beginning with digestion of
the vector and DNA through the use of restriction endonucleases, ligating the sticky or
blunt ends of the vector and plasmid, followed by inserting the recombinant vector to a
host cell, where the host cell produces many copies of recombinant DNA. Adapted from
Lehninger Principles of Biochemistry, 6th Edition (Nelson & Cox, 2012).
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2.1.1 Amplification of Gene Sequences through Polymerase Chain Reaction
Polymerase chain reaction (PCR) is a revolutionary technique developed by Kary
Mullis in the 1980s. It is used to synthesize many copies of a specific DNA sequence. The
process begins with designing oligonucleotides, short single stranded sequences of
nucleotides, that complement approximately 18-24 bases at the 5’ and 3’ ends of the
target DNA sequence for generating many copies of the gene. The reaction goes through
a series of temperature changes that can allow certain reactions to occur (Figure 2.2).
The reaction mixture is heated to 98ºC to denature double stranded DNA, and then cooled
60ºC-70ºC to allow the primers to bind to the 3’ ends of the single stranded DNA. The
primed segment is then replicated at 72ºC by a heat-stable DNA polymerase, that adds
nucleotides to the preexisting strands. The cycles of heating, cooling, and replication are
repeated 25 to 30 times over a few hours. The final product is many copies of the amplified
DNA that can be readily used for cloning.
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Figure 2.2 A schematic diagram of the cycles in the polymerase
chain reaction with a final product showing many copies of the initial
gene. Adapted from Giri, 2015 (Giri, 2015).
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2.1.2 The Components of a Plasmid
A plasmid is a circular DNA that is used as cloning or expression vector each
having their own properties to replicate inside the host organism (Figure 2.2). All vectors
have an origin of replication sequence where replication is commenced by cellular
enzymes. Another vital property is that plasmids contain genes that allow them to be
resistant to some antibiotics such as ampicillin, permitting the selection of cells that
contain the vector to survive and replicate. Another unique feature is the multiple cloning
site that contains sequences for restriction endonuclease recognition where the plasmid
can be cut to insert foreign DNA.

Figure 2.3 A map section of an expression vector system that contains a selection
marker for antibiotic resistance. A multiple cloning site, an origin of replication that
denotes how many copies are produced depending on the expression vector. Affinity
tags and promoters that are recognized by some polymerases such as T7 polymerase.
Adapted from Rosano & Ceccarelli, 2014 (Rosano & Ceccarelli, 2014).
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2.1.3 Bacterial Transformation
Bacterial transformation is a step where bacterial cells uptake foreign genetic
material through heat shock that is done by rapidly shifting the temperature. Bacteria that
have the ability to take up exogenous DNA are termed competent cells. These cells
contain calcium or other divalent cations that are bound to the cell membrane that attract
and stabilize the negatively charged DNA to enter the cell. The bacterial membrane
becomes permeable upon heat shock and takes up the plasmid DNA. The next step
involves screening for cells that contain the plasmid by growing the cells in nutrient-rich
medium (e.g. LB Agar) that contain the selectable marker in the form of an antibiotic. Cells
that uptake the plasmid would have an antibiotic resistance factor that would select for
survival against the antibiotic that is present in the media. Cells that do not have plasmid
are susceptible to the antibiotic in the media and are therefore unable to propagate.
2.2 Protein Expression and Purification
2.2.1 Bacterial Expression of Recombinant Protein
Bacterial expression of recombinant proteins has given the opportunity for
biochemists to produce high quantities of proteins. Escherichia coli is one of the most
popular organisms for the production of recombinant proteins. The gene of interest is
cloned into an expression vector, such as a pET system vector, then transformed into an
expression host like BL21 (DE3), and finally the cells are grown in rich media where the
protein is induced in the presence of lactose or lactose analogs. The strategy used for
protein production is done by the modification of E. coli’s genome to contain a copy of the
T7 RNA polymerase found in bacteriophage T7. This polymerase results in the
transcription and subsequent translation of the target gene (Figure 2.4). The process
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begins with the lac repressor binding to the lac operator that regulates the promoter
upstream of the gene encoding for expression of T7 polymerase. In the presence of an
inducer, for example isopropyl b-D-1-thiogalactopyranoside (IPTG), an analog of lactose,
binding to the lac repressor causes a conformational change that leads to the repressor
falling off the operator resulting in the liberation of the promoter and concomitant
production of T7 polymerase. In the pET vector system, the T7 RNA polymerase
selectively binds to the T7 promoter, and upon removal of the repressor located upstream
from the target gene by IPTG, transcription of the gene followed by translation occurs.
(Figure 2.4). To control basal expression, glucose may be added to avoid leaky
expression via regulation of the lac repressor.

Figure 2.4 The regulation of transcription in a host cell for obtaining recombinant
protein using T7 RNA polymerase and IPTG. Adapted from the pET Manual
(PET system manual, n.d.).
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The amount of recombinant protein obtained from the bacteria can result in high
concentrations. However, some problems can occur, such as the cells not growing,
inclusion body formation, protein inactivity, or not obtaining any protein. There are
optimizations such as expressing protein at lower temperatures, using different
concentrations of IPTG, using a different vector system, changing the media, or choosing
promoters with tighter regulation. All of which can contribute to higher yields of protein.
2.2.2 Protein Extraction
The target protein is extracted from cells by following a variety of procedures that
can either be physical or chemical in nature. Some of the procedures depend upon the
isolation of the protein in terms of sample type, location of the protein of interest, the
stability, and the required protein yield. Cells can be lysed through the following
mechanisms: freeze thawing, sonication, pressure homogenization, osmotic and
chemical lysis (Traditional methods of cell lysis , n.d.). Freeze-thaws is the gentlest
procedure where multiple cycles of freeze-thaws cause the cells to swell as ice crystals
form during the freezing process, allowing the cell wall to break. In addition, additives
such as lysozyme and lysis buffer that contains EDTA, facilitate the process of physical
disruption. EDTA is a chelating agent the sequesters divalent cations that support the
stability of the outer membrane of gram-negative bacteria (Alakomi, Paananen, Suihko,
Helander, & Saarela, 2006) (Alakomi , Saarela, & Helander, 2003) (Vaara, 1992) (Block,
2001). Lysozyme can then pass through the disrupted membrane, where it damages the
glycosidic linkages that support the peptidoglycan.
As cells are lysed, the controlled environment the cell was initially in is disturbed,
allowing endogenous proteases and phosphatases to become unregulated and result in
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proteins that are degraded (Overview of cell lysis and protein extraction, n.d.). To prevent
these effects, protease inhibitors such as AEBSF and PMSF are added to lysis reagents
and the rest of the steps in protein extraction.
2.2.3 Fast Protein Liquid Chromatography
Fast protein liquid chromatography (FPLC) is a medium-pressure chromatography
that was introduced in 1982 by Pharmacia (Fast protein liquid chromatography , n.d.).
Since then many different medium-pressure chromatography systems have been
improved and developed for purification of proteins. The system consists of a pump, a UV
detector, conductivity meter, and a fraction collector (Figure 2.5). Some systems also
have column switching valves and buffer blending valves to generate a gradient. Samples
can either be loaded by injection into a sample loop or a sample pump.

Figure 2.5 A schematic diagram of a liquid chromatography system, composed
of a pump, mixer, sample application, a detector, and fraction collector.
Adapted from Introduction to practical biochemistry (6.5 High performance
(high pressure) liquid chromatography (HPLC), n.d.).
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This technique is useful for separation of proteins based on their physical and
chemical properties. The system works by the liquid mobile phase, or the buffer, passing
through the column, where the molecules present in the buffer, are separated based on
their

physiochemical

interactions

with

the

stationary

phase

(resin)

(Liquid

chromatography principles, n.d.). Some of these interactions are based on molecular size,
hydrophobicity, specific binding interactions, and charge interactions. Each type of
interaction corresponds to columns that are purposely designed for these specific
interactions between the protein and the resin.
2.2.3.1 Ion-exchange Chromatography
Ion-exchange chromatography is a type of column designed to separate proteins
based on their total surface charge (Figure 2.6). To determine the overall surface charge,
the isoelectric point (pI) of the protein is calculated based on the primary sequence of the
protein (Ion exchange chromatography, n.d.). This value represents the pH at which the
protein has no net charge. The choice of pH in the buffer determines the net charge of
the protein of interest (Ion exchange chromatography, n.d.). For example, isolation of an
isoelectric point that is 5.9 and a buffer with a pH of 7.5 would be carried out by using a
positively charged resin column (anion exchange) due to the protein sample having a net
negative charge, whereas an isoelectric point value that is higher than pH of 7 would be
supported by a column with a negative charged immobilized group (cation exchange)
where a positively charge protein can bind. The workflow of the ion exchange column
after loading the crude sample, is done by washing the column with buffer that contains
a low concentration of salt to washout weakly bound proteins or proteins that did not bind
to the column. After this, the system is set up to elute the protein of interest based on a
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salt gradient. As the charged salt ions pass through the stationary phase, the salt ions
compete with bound proteins. Proteins with a low net charge would elute with low
concentrations of salt, whereas proteins with many charged groups would or a high net
charge elute with a higher concentration of salt.

Figure 2.6 Ion exchange column composed of negative charged
resin (cation exchange) bound with positive charged protein.
Proteins that are net negatively charged cannot bind to the resin
and are eluted earlier. Adapted from Lehninger Principles of
Biochemistry, 6th Edition (Nelson & Cox, 2012).
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2.2.3.2 Size-exclusion Chromatography
Size-exclusion chromatography is a column that is used to isolate molecules based
on their size (Figure 2.7). There are a variety of size-exclusion columns that are
composed of different pore sizes and column lengths (Introduction to size exlusion
chromatography, n.d.). The pore size and column length contribute to the resolution of
separated protein mixtures. Columns such as the superpose 6 increase has small
spherical bead size of 8.6 µM that results in higher purity and increased resolution
(Superose

6

Increase,

n.d.). A protein mixture of
small and large proteins is
separated based on the
particle migration. Larger
proteins cannot enter the
pores and result in eluting
earlier (Hong, Koza, &
Bouvier, 2012). Proteins
that are smaller ultimately
are retained in the beads
longer and therefore elute
last.
Figure 2.7 Size-exclusion column composed of porous
polymer beads. Smaller proteins enter through these beads
whereas proteins that are larger can pass through more
freely, and elute earlier. Adapted from Lehninger Principles
of Biochemistry, 6th Edition (Nelson & Cox, 2012).
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In ion and size-exclusion columns, as the buffer continues to flow through the
stationary phase, the fractions are collected while monitoring the conductivity and
absorbance of the compounds eluted from the column over time, forming an elution curve
or chromatogram. The resulting chromatogram is then analyzed to locate protein of
interest. Each distinct peak is a representation of a unique component that may contain
more than one protein species. Therefore, further analyses of the eluted fractions can be
seen by an SDS-PAGE.
2.2.4 Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS)
SDS-PAGE is a technique used to separate proteins by size. The gel is commonly
used for visualizing proteins molecular mass in kiloDalton (kDa), the abundance of major
proteins in a sample, and the purity of the protein. This method uses a polyacrylamide gel
as a support for migrating proteins and SDS along with a reducing agent (betamercaptoethanol) to denature proteins. The hydrophobic tail of the SDS denatures the
structure of the complexed proteins making them into a linearized negatively charged
protein. Also, beta-mercaptoethanol reduces the disulfide bonds of the protein, resulting
in a destabilized structure.
The polyacrylamide gel has two different layers, the first layer known as the
stacking layer that permits the protein samples to begin migrating at the same rate in time.
The second layer or resolving layer responsible for separating the polypeptides by size.
The linearized negative proteins always migrate towards the anode side that is positively
charged in an electric field. Proteins with a higher molecular mass migrate slowly through
the porous acrylamide gel compared to proteins that are smaller, which migrate faster
through the gel.
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2.3 Biophysical Analyses of Proteins
2.3.1 Circular Dichroism
Circular dichroism (CD) is a method used to understand the secondary structure
of a protein in solution. The instrument (Figure 2.8A) is composed of an un-polarized light
that is vibrating in more than one plane: horizontal, vertical, and side to side directions.
The instrument also has a photoelastic modulator (PEM) that is an optical devise that
modulates the polarized linear light (light moving in one direction: vertical or horizontal)
to circular polarized light, meaning the light can travel in both circular directions, lefthanded (counterclockwise) and right-handed (clockwise) (Circular Dichroism, 2014). As
these two directions of light pass through the molecule, they begin to interact and the
molecule may absorb right and left handed circularly polarized light to different extents
(Greenfield, 2006). This interaction excites the molecule causing it to transition and
rearrange. The remainder of light that is not absorbed will travel in the direction of a
detector where the result is of different structural signatures (Figure 2.8B). A protein
sample with alpha-helical structure have negative bands at 222 nm and 208 nm forming
a “W” shaped signature and also have positive bands at 193 nm, disordered proteins emit
a wavelength above 210 nm and negative bands near 195 nm. Proteins with well-defined
antiparallel beta-pleated sheets have negative bands at 218 nm and positive bands at
195 nm (Greenfield, 2006). The difference in molar extinction coefficients for left and righthanded circularly polarized light (∆e) is plotted as a function of wavelength within 190 and
250 nm (Nelson & Cox, 2012).
It is worth noting that CD spectroscopy is a good source for determining whether
proteins are properly folded, estimating the fraction of secondary structure of the protein,
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and monitoring transitions between folded and unfolded protein states (Nelson & Cox,
2012).
A

B

Figure 2.8 Instrumentation for CD spectrometer showing linear polarized light
and the direction of right-handed circular polarized light and left-handed
circular polarized light (A), the spectra showing different signatures of
secondary structure (B). Adapted from Lehninger Principles of Biochemistry,
6th Edition (Nelson & Cox, 2012), and LibreTexts, Circular Dichroism (Circular
Dichroism, 2017).
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2.3.2 Dynamic Light Scattering
Dynamic light scattering (DLS) is a biochemical analysis that is often employed to
measure the particle size distribution of a protein in solution. This method follows the
Brownian motion, where particles in a solution result in different motions based on their
thermal energy (Worldwide, 2011) (Figure 2.9). When the molecules are illuminated with
a laser in this case a monochromatic laser, the intensity of the scattered light causes the
molecules to move more rapidly (Worldwide, 2011). These results are mathematically
translated into a size distribution or Gaussian curve (Figure 2.9). Not only is the particle
size detected but the also the surface structure. In solution, the surface structure of the
molecule can be made up of a single population of identical particles, also known as a
monodisperse sample or two or more populations characterized as a polydispersed
sample, or non-uniform size distribution. The different populations (monodisperse and
polydisperse) are detected by a value known as polydispersity index (PDI). A PDI value
less than 0.05 indicates a monodisperse protein and values above 0.7 indicates a
polydisperse protein (Worldwide, 2011).
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Figure 2.9 Represents the analysis of fluctuation of scattering light based
on the size of the particle. Adapted from Otsuka, Principle of particle
sizing: Dynamic Light Scattering Method (Dynamic Light Scattering
Spectrophotometer DLS-8000 | Otsuka Electronics, n.d.).
2.4 Electron Microscopy
2.4.1 Instrumentation
A transmission electron microscope (Figure 2.10A) is an instrument designed for
studying high resolution structures of viruses, organelles, and proteins. The microscope
is a high vacuum cylindrical tube that is about 2 meters long. In the electron microscope,
an electron beam hits the sample where the electrons interact with the atoms to form an
image. The source of electrons is produced by thermo-ionic emitter that works like a light
bulb. An accelerating voltage is applied to the surrounding cathode cap also known as
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Wehnelt cylinder (Transmission Electron Microscopy, n.d.) (Figure 2.10B). A small
emission current is then applied to a filament (cathode) where electrons are released.
The change in negative voltage between the filament and the cathode cap creates an
electron cloud (Transmission Electron Microscopy, n.d.). The electrons are rapidly moving
due to the repulsion of the cathode cap. An anode located below the electron gun, attracts
the negatively charged electrons where they accelerate through a channel where
electromagnetic converging lenses are applied. The lenses are coils that surround the
tube at different intervals. The electromagnetic field emitted by the coils causes the
electrons to constrict and focus at the center of the sample (Transmission Electron
Microscopy, n.d.) (Figure 2.10C). A condenser aperture controls the fraction of the beam
that hits the sample, for controlling the intensity of illumination and preventing a blurry
image. The specimen stage is located within the objective lens to magnify and focus the
image. Below the stage, an objective aperture is used to enhance the contrast of the
sample, as well as a projector lens to further magnify the image (Transmission Electron
Microscopy, n.d.). The final result is the formation of an image composed of dark particles
that are present on a white background.
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B

C

Figure 2.10 Set up of a transmission electron microscope (A). The set up of the
electron gun for emission of electrons (B). The electron trajectory in a magnetic field
lens (C). Adapted from the University of Iowa’s Center for Microscopic Analysis
(Transmission Electron Microscopy, n.d.).

2.4.2 Specimen Preparation for Negative Staining
Proteins and other biological molecules can be difficult for electron microscopy
because of their sensitivity to radiation damage, poor capacity to scatter electrons, and
prone to dehydration in the vacuum of the microscope (Ohi, Li, Cheng, & Walz, 2004).
Therefore, the method for specimen preparation is considered when evaluating them
under a microscope. The preparation of sample helps to prevent structural collapse of the
protein and increase contrast. Negative staining is a method where the specimen is
embedded in a layer of a dried heavy metal solution. This method was introduced as a
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technique that allows for finer details of the molecules to be visualized due to the increase
in contrast that comes from the interactions that occur between the electrons and the
atoms of the heavy metals.
The sample to be imaged is prepared on a small grid (Figure 2.11). The grid is
made up of a copper-coated film. A thin layer of sample is added on top of the carbon
film. However, carbon is hydrophobic and any hydrophilic liquid that is layered above it
will not interact. Therefore, to make the surface more accessible to the sample, the grid
is placed under a high vacuum seal where glow-discharging is done resulting in a
hydrophilic grid. When high voltage is applied this ionizes the gases within the chamber.
The negative charged ions are deposited onto the copper-coated grid, resulting in a
hydrophilic surface. Negative stains composed of heavy metals are added to the surface
of the specimen to improve the amount of electrons that are absorbed. The most common
stains are uranyl and tungstate stains. Each time the specimen is coated with a heavy
metal stain, it is carefully blotted to remove any excess of stain (Ohi, Li, Cheng, & Walz,
2004). Removing the excess stain prevents unwanted artifacts that can appear in the
imaging process. After staining, the specimen is ready to be examined under the
microscope. In negative staining the particles of interest appear as white spots against a
dark background.
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Figure 2.11 A schematic of specimen preparation: sample, negative stain composed of
a heavy metal, blotting, and image formation. Adapted from Orlova, 2011 (Orlova,
2011).
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Chapter 3: Experimental Approaches for Hsp27 and point mutation S135F
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3.1 Cloning Heat Shock Protein 27
Primers were designed by obtaining the HSPB1 DNA sequence (ID: 3315) that
encodes for Hsp27 protein from the National Center for Biotechnology Information
website. The following sequence primers were designed and ordered from Integrated
DNA Technologies (IDT):
Coding for Hsp27 WT
Forward 5’ – TTT TCA TAT GAC CGA GCG CCG CGT CCC CTT CT – 3’
Reverse 5’ – TTT TCT CGA GTT ACT TGG CGG CAG TCT CAT CGG – 3’
Coding for S135F point mutation in Hsp27 WT
Forward 5’ - GGC TAC ATC TTC CGG TGC TTC – 3’
Reverse 5’ – TGA AGC ACC GGA AGA TGT AGC C – 3’
Hsp27 WT was amplified in a 50 µl reaction that contained 0.5 µM of forward and
reverse primers, 45 ng/µL of Hsp27 template, 1X of Phusion HF, 200µM of dNTP mix,
and 1 unit/50µL Phusion DNA Polymerase. The reaction took place in a PCR machine
from Prime Thermal Cycler. The reaction began as follows: initial denaturation at 98ºC for
30 seconds, followed by 30 cycles of DNA amplification that consisted of denaturation at
98ºC for 5 seconds, annealing at 65ºC for 5 seconds, elongation at 72ºC for 5 seconds
with a final extension at 72ºC for 10 minutes. The PCR product was purified by using the
protocol from QIAGEN QIAquick PCR Purification kit.
S135F was amplified by doing three separate PCR reactions where the third
reaction would include the products from the first two PCR reactions. In the first PCR
reaction, the following primers were used:
Forward 5’ – TTT TCA TAT GAC CGA GCG CCG CGT CCC CTT CT – 3’
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Reverse 5’ – TGA AGC ACC GGA AGA TGT AGC C – 3’
In the second PCR reaction, the following primers were used:
Forward 5’ - GGC TAC ATC TTC CGG TGC TTC – 3’
Reverse 5’ – TTT TCT CGA GTT ACT TGG CGG CAG TCT CAT CGG – 3’
Both reactions were set up in a total volume of 50 µl that included 0.5µM of forward
and reverse primers, 45 ng/µL of Hsp27 template, 1X of Phusion GC Buffer, 200µM of
dNTP mix, and 1 unit/50µL Phusion DNA Polymerase HD. The reaction began as follows:
initial denaturation at 98ºC for 30 seconds, followed by 30 cycles of DNA amplification
that consisted of denaturation at 98ºC for 5 seconds, annealing at 61ºC for 5 seconds,
elongation at 72ºC for 5 seconds with a final extension at 72ºC for 10 minutes. The third
PCR reaction consisted of 20 µL of each PCR product that was combined together with
200µM dNTP mix, and 1 unit/50 µL Phusion DNA polymerase HD. The final reaction
began as follows: initial denaturation at 98ºC for 30 seconds, followed 30 cycles of
denaturation at 98 ºC for 5 seconds, annealing at 67.05 ºC for 30 seconds, elongation at
72 ºC for 20 seconds with final extension at 72 ºC for 10 minutes. The PCR product was
purified by following the protocol from QIAquick Gel Extraction and PCR Clean-up kit. 6
µls of the three reactions were loaded onto a .7% DNA agarose gel for analysis of product
(Figure 3.1).
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Figure 3.1 .7% agarose gel with PCR products of three reactions that were
done to add the mutation S135F. The two PCR products were combined
to obtained the final product with the mutation S135F. Sybr Safe from
Invitrogen was used to stain the DNA and emit fluorescence when placed
under blue light.
Double digestion was done by following the protocol from New England BioLabs
(NEB) website. Two 50 µL reactions one with 1 µg of S135F DNA and the other with 1
µg of pET22 (b) that contained 1X Cut Smart buffer, 2 µl of NdeI and 2 µl of XhoI. Both
digestions were set to incubate at 37 ºC for 2 hours, followed by inactivation at 65 ºC for
20 minutes. The digested product for S135F and pET22 (b) was cleaned up by following
the protocol from NucleoSpin gel where a final concentration of S135F 110.5 ng/µl and
pET22 (b) 2089.72 ng/µl was measured at an absorbance of 260nm with
spectrophotometer. 6 µl of DNA and plasmid digestion were loaded onto a .7% DNA
agarose gel for analysis (Figure 3.2).
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Figure 3.2 .7% agarose gel that contains the products
of the before and after digested pET vector and S135F.
Sybr Safe from Invitrogen was used to stain the DNA
that emit fluorescence when placed under blue light.

Ligation of vector pET22 (b) with S135F was followed by using the protocol from
New England BioLabs website. The reaction was set to a total volume of 14 µl with a ratio
1:4 of 16 ng/µl of gene and 14.5 ng/µl of plasmid with 7 µl of T4 DNA Ligase Master mix.
The reaction was mixed by pipetting up and down 7-10 times and placed on ice where it
was ready for bacterial transformation.
The obtained recombinant pETT22 (b)-HSPB1 was transformed into E. coli
BL21(DE3) competent cells. The frozen competent cells were placed on ice until
completely thawed out, followed by mixing 14 µl of pETT22 (b)-HSPB1 with cells and
incubated on ice for 30 minutes. The mixture was moved to a water bath set to a
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temperature exactly 42ºC for 10 seconds to allow the calcium chloride in the mixture to
disrupt the cell membrane where pETT (b)-HSPB1 can enter. The mixture is moved back
on ice for 5 minutes where it was mixed with 950 µl of SOC media that contains nutrients
for cell growth. The cells were plated onto agar plates that contain nutrients for cell growth
and 100 µg/ml ampicillin resistance for growth of only resistant colonies containing the
cloned plasmid. The plates were moved to an incubator set to 37 ºC and left overnight.
The colonies were then identified for the uptake of pETT22 (b)-HSPB1 through colony
PCR (Figure 3.3).

Figure 3.3 .7% agarose gel shows the colonies that
have the DNA sequence S135F. Meaning that the
cells were able to uptake pET22 (b) with HSPB1
mutation. Sybr Safe from Invitrogen was used to
stain the DNA and emit fluorescence when placed
under blue light.
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Colonies 1-6 contained the pET22 (b)-HSPB1. pET22 (b)-HSPB1 expression were
inoculated into a 100 mL baffled Erlenmeyer flask that contained 50 mLs of 2XTYmedia
with 100 µg/ml of ampicillin. The cells were incubated in a shaker at 37ºC, at 220 rpm.
After a few hours, the optical density (OD) for the cell reached .03-.4 at a wavelength of
600nm. This means that the cells were in their log phase or healthier. 25 mLs of the
culture was mixed with 25 mLs of 50% glycerol diluted by 2XTY media. A total of 50 mLs
were aliquoted into 1 mL eppendorfs for colonies 1-8 and stored in a -80 freezer for long
term storage. The rest of the culture was left incubating until it reached an OD600 of .6.8 where IPTG with a final concentration of 1mM was added for the induction of
recombinant protein for 1 hour. A 10% SDS-PAGE was run for the analysis of the protein
expression of the two colonies 5 and 7 (Figure 3.4A). Another 10% SDS-PAGE was run
for the protein expression level for colonies 1-4, 6 and 8 (figure not shown). Colony 5 was
picked for purification because it did not express protein of interest when no IPTG was
added, that means that it did not have a leaky promoter (Figure 3.4B).
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B

A

Figure 3.4 10% SDS-PAGE gel for testing protein expression with 1mM IPTG for 1
hour (A) 10% SDS-PAGE gel for protein expression with 1mM IPTG for 2 hours
(B).

3.2 Optimization of Protein Expression Levels for Soluble Protein
Hsp27 was expressed at different concentrations of IPTG for increasing the
amount of soluble protein. A culture was prepared by adding 100 µl of glycerol stock of
Hsp27 WT into a 100 mL 2XTY with 100 µl of 100 µg/ml ampicillin and incubated at 37ºC.
Once the OD600 reached between .6-.8, the 100 mL culture was divided into smaller
cultures where 1mM and 4mM IPTG was added to each culture and checked every hour
for a total time of 3 hours at 30ºC. 1 mL of culture was pipetted out and centrifuged where
the pellet was re-suspended with 500 µl of DI water. The samples were loaded onto a
10% SDS-PAGE gel (Figure 3.5) for protein expression levels.
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Figure 3.5 10% SDS-PAGE showing the amount of
protein that is expressed when using different
concentrations of IPTG over time at a temperature of
30ºC.
3.3 Cell Lysis
The cells were harvested by centrifugation at 6,000xg for 30 minutes at 4ºC. The
cell pellet was re-suspended with lysis buffer (10 mMHepes pH 7.5, 5mM EDTA pH7.5),
followed by the addition of 2mM PMSF and a pinch of Hen egg white lysozyme (Sigma,
USA). The mixture was incubated in a Hula shaker at 4ºC for 1 hour to mix thoroughly.
The mixture was then placed in a -20 freezer for initial freezing. Three cycles of freezethaws were applied to allow ice crystals to disrupt the cell membrane. The addition of
2mM PMSF was added after each thaw. The DNA was degraded by using the DNase I
(Sigma, USA) and 60mM MgCl2. The mixture was placed in the Hula shaker for 30
minutes until the mixture became liquid. An addition of 3% of Streptomycin was added to
the mixture and placed back in the Hula shaker for 30 minutes. The mixture was
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centrifuged at 12,000xg for 30 minutes at 4ºC. The supernatant was transferred into a
clean 50 mL tube where a gradient from 30% to 60% Ammonium Sulfate as a prepurification step was added to locate the precipitated protein. A 10% SDS-PAGE was run
for the analysis of precipitated protein at a different percentage of ammonium sulfate
(Figure 3.6). The sample was mixed in the Hula shaker for 15 minutes and spun down at
12,000xg for 30 minutes at 4ºC. The recombinant protein remained in the 30% ammonium
sulfate pellet where it was re-suspended with 2-4 mLs of chromatography buffer A (10mM
Hepes pH 7.5, 5mM EDTA pH 7.5), until the solution appeared a tea-like color. 1 mL
aliquots were stored in a -80 freezer for long term storage. The same procedure was
followed for the mutation S135F.

48

Figure 3.6 10% SDS-PAGE showing a
gradient of ammonium sulfate at different
concentrations to locate at which
concentration Hsp27 precipitates.
3.4 Purification of Hsp27 and mutation S135F
The isoelectric point (pI) for Hsp27 was detected by adding the amino acid
sequence onto ExPASy Bioinformatics Resource Portal website. The program revealed
a theoretical pI of 5.98, that meant that it is composed of mostly negative charged amino
acids at physiological pH 7.5. Therefore, the proteins were loaded onto an anion
exchange column that contains positive charged immobilized groups. A column called
HiTrap Q-XL from GE Healthcare Life Sciences was equilibrated first with 2 column
volumes (CV) of chromatography buffer B (10 mMHepes pH 7.5, 5mM EDTA pH 7.5, 1M
NaCl) then with 10 mLs of chromatography buffer A (10 mM Hepes pH 7.5, 5 mM EDTA
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pH 7.5) at a flow rate of 5 mLs/min. 1 mL of crude protein was diluted in 20 mLs of
chromatography buffer A (10mM Hepes, 5mM EDTA) and loaded through the sample
pump to travel in the column at a flow rate of 2 mLs/min. 2 CV of buffer A was passed
through the column to washout unbound protein. After washing, the proteins eluted with
a linear gradient starting at 0 NaCl to 1M NaCl in 10mM Hepes pH 7.5 and 5mM EDTA
pH 7.5. A 12% SDS-PAGE was done for the location of Hsp27. Fractions containing
Hsp27 protein were transferred into a 30,000kDa Vivaspin 6 centrifugal concentrator unit
and spun down at 4,000xg at 4ºC until the sample was a total of 200 µls. The 200 µls
were injected into an AKTA purifier and loaded into a size exclusion column, Superose 6
Increase from GE Healthcare Life Sciences. The column was pre-equilibrated with 1 CV
of chromatography buffer A (10mM Hepes pH 7.5, 5mM EDTA pH 7.5, 100mM NaCl).
Collected fractions were loaded to a 12% SDS-PAGE (shown in results section). The
fractions that contained the protein of interest were pooled and concentrated via a
10,000kDa Vivaspin 6 centrifugal concentrator unit. A 12% SDS-PAGE of the protein was
done to see the final purity of the combined fractions that were concentrated (shown in
results section) by loading 1 µl of protein in 4 µl of 4x loading SDS buffer (40% Glycerol,
240 mM Tris/HCl pH 6.8, 8% SDS, 0.04% bromophenol blue, 5% beta-mercaptoethanol).
A pierce BCA assay was conducted to measure the final concentration of the pure protein
for further assays. The same procedure was reproduced for S135F.
3.5 Chaperone Activity Assay of Hsp27 and S135F
The concentration of the protein was measured by BCA (Bicinchoninic acid) assay
with BSA (bovine serum albumin) protein standard at a wavelength of 562nm. The activity
assay was done by following the protocol from Bumagina, 2010. To measure the

50

chaperone activity of Hsp27, alpha-lactalbumin from Sigma was used as the substrate
when reduced by a reducing agent, Dithiothreital (DTT). A 50 µl reaction was prepared
by adding .85mg/mL of alpha-lactalbumin (100mM sodium phosphate buffer, 300mM
NaCl, 1mM EDTA pH 6.2) inside a Quartz cuvette. The reaction was initiated by the
addition of 35mM DTT and the mixture was moved to a PASCO spectrophotometer where
the temperature was controlled to 37ºC and the absorbance was measured every 2
seconds at a wavelength of 400nm. A 1:1 reaction of 50 µl was set up by the addition of
60µM alpha-lactalbumin and 60µM of chaperone Hsp27. The reaction was commenced
with the addition of 35mM DTT. The control was set to include 60µM alpha-lactalbumin
without chaperone, 35mM DTT was added. The mixture was moved to the
spectrophotometer, where the absorbance was measured. The reaction was repeated at
another concentration 100µM of chaperone and 100µM of substrate. The same set up
reaction was done for the chaperone Hsp27 with the mutation S135F.
3.6 Negative Staining
3.6.1 Negative Staining Sample Preparation
The concentration of pure protein was measured via BCA assay. 2% heavy atom
uranium and methyl amine tungstate solutions were prepared by dissolving each in 1 mL
of water. The samples were vortexed to ensure the heavy metal salt dissolved in water.
The resulting solution was centrifuged at 12,000xg for 10 minutes. Meanwhile, a 400mesh copper was discharged for 30 seconds by using the PELCO easiGlow Glow
Discharge Cleaning System from TED PELLA INC, USA. The purified protein was then
diluted to a final concentration of .1 mg/mL with chromatography buffer A (10mM Hepes
pH7.5, 5mM EDTA pH 7.5, and 100mM NaCl). Once the surface of the grid was
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discharged, the grid was picked up with a sharp-end tweezer where 3 µl of protein was
embedded onto the carbon coated side. The excess protein was blotted off with white
filter paper angled at 45º. 3 µl of 2% methyl amine tungstate was added to the coated
surface of the protein followed by blotting the excess sample with filter paper. This was
repeated twice by using uranium to make sure the heavy metal solution covers the protein
to protect it from ionizing and generating radicals that damage the protein.
3.6.2 Negative Staining Data
The sample was then imaged by Dr. Ricardo Bernal that used a JEOL 3200FS
transmission electron microscope at 300,000V with an emission gun that releases
electrons towards the sample.
3.7 Biophysical Analyses
3.7.1 Circular Dichroism (CD)
A BCA assay was done on pure protein sample to measure the concentration of
the protein at a wavelength of 562nm. The protein was then diluted with chromatography
buffer A (10mM Hepes, 5mM EDTA, 100mM NaCl) at different concentrations: 60µM,
100µM, and 200µM. 30 µl of diluted sample was spread onto a .1mm cuvette glass plate
for 100µm path length. The sample was recorded with a circular dichroism spec from
Jasco J 1500 at 4ºC every 1nm, between wavelength 190nm and 260nm. Several cycles
were done to assess the dynamics of the protein’s secondary structure. This was
repeated by changing the temperature of CD: 5ºC, 25ºC, 37ºC, and 42ºC with a sample
concentration of 100µM.
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3.7.2 Dynamic Light Scattering (DLS)
A BCA assay was done to measure the concentration of the protein for dynamic
light scattering analysis. The protein was diluted to .5mg/ml in 1 mL of Chromatography
Buffer A (10mM Hepes, 5mM EDTA, 100mM NaCl). The sample was transferred into a 3
mL cuvette where it was placed inside a DLS machine from Malvern. The machine was
set to do the following measurements at different temperatures: 5ºC, 25ºC, 37ºC, and
42ºC. The measurements were recorded every 2 seconds for a total of 40-100 cycles.
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Chapter 4: Results, Discussion, and Conclusion
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4.1 Purity Analyses of Hsp27 WT and S135F
Isolating the protein of interest through chromatography, is vital for the
characterization of the structure and function. As mentioned in chapter 1, Hsp27 is
composed of different sizes, resulting to its unique functions in cells. Here, we isolated
the bigger complex of Hsp27 to study its primary function as a chaperone.
Hsp27 WT was expressed at a higher temperature for 3 hours. The protein was
loaded onto the ion-exchange followed by size-exclusion column. The fractions B8-B10
had the protein of interest, however, the chromatogram (figure not shown) showed an
absorbance of 15 mAU, meaning there was not enough protein for the use of assays.
Due to this, the protein was induced at a lower temperature and expressed for 20 hours
with .1mM IPTG. The cell extraction was still prepared as mentioned in Ch.3. The
protein was purified through the ion-exchange followed by size-exclusion column. The
new chromatogram (figure not shown) of Hsp27 WT showed an absorbance of 283 mAu
indicating more protein for conducting assays. The fractions tube number B8-B12 were
pooled and concentrated together by a concentrating unit. Expressing the protein at a
lower temperature was improved for obtaining a higher concentration of soluble protein.
The same was done for mutation S135F. The protein samples of Hsp27 WT and S135F
were added to a 12% SDS-PAGE to confirm the purity of each (Figure 4.1 A & B).
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A

B

Figure 4.1 12% SDS-PAGE for concentrated fractions of Hsp27 WT (A) and
S135F (B) after a two-column purification, ion-exchange followed by sizeexclusion column.
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4.2 Chaperone Activity for mutation S135F compared to Hsp27WT
In this assay, we wanted to study the primary function of chaperone Hsp27 WT
and the mutation S135F involved in CMT, at normal human body temperature 37ºC. We
used alpha-lactalbumin as a substrate for Hsp27. Based on the size-exclusion column,
the larger complex of Hsp27 WT was able to protect misfolded alpha-lactalbumin that was
induced by the addition of DTT (Figure 4.2A). These results were interesting because
other papers (Rogalla, et al.) (Lelj-Garolla, 2006) (Panasenko, Seit Nebi, Bukach,
Marston, & Gusev, 2002) were not clear in which small or large complex of Hsp27 is the
active chaperone function. In these results, we confirmed that the larger complex is the
active chaperone in vitro.
In the chaperone assay for S135F mutation in Hsp27, we saw that it protected
alpha-lactalbumin for about 4 minutes, but the absorbance started to increase up to 1.5
mAu (Figure 4.2A). It was observed that the absorbance increased much higher than the
control that was alpha-lactalbumin with 35mM DTT. This was interesting to see because
previous papers had published that the mutation S135F had high chaperone activity
(Almeida-Souza, et al., 2010). However, that statement was not clear in whether it
protected the client protein from aggregating or the chaperone would bind tightly to the
protein when misfolded. Based on this result, a 12% SDS-PAGE was done to analyze the
precipitated sample to locate if S135F was precipitating with the substrate. The SDSPAGE (Figure 4.2B) shows that S135F is in the pellet in the presence of alphalactalbumin, meaning that its chaperone properties is that it binds tightly to the client
protein and precipitating with it. To make sure that DTT was not inducing the aggregation
of S135F, a control where S135F and DTT without substrate was followed (Figure 4.3).
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The results confirmed that DTT is not inducing the aggregation of S135F but instead
S135F cannot protect misfolded protein, leading to both aggregating and precipitating.

A

B

Figure 4.2 Red line indicates the control where no chaperone is
added. Green line represents chaperone activity for mutation S135F
with alpha-lac. Blue line indicates the chaperone activity of wild-type
with alpha-lac (A). 12% SDS-PAGE gel showing the pellet of the
precipitated proteins from the chaperone assay (B).
58

Figure 4.3 Green line represents the chaperone activity for mutation S135F.
Orange line indicates the chaperone S135F with DTT only.
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4.3 Secondary Structure of mutation S135F and Hsp27 WT
Hsp27 WT and mutation S135F showed different chaperone functions. Hsp27 WT
can protect misfolded protein from aggregating unlike S135F that binds to the misfolded
protein and completely aggregates. Because the chaperone activity assay for Hsp27 WT
and mutation S135F are different, that must mean the structure is also different. To study
the structural change between wild-type and the mutation, we did circular dichroism.
Published data reported that the structure of Hsp27 is concentration dependent,
meaning that the structure changes at different concentrations (Shashidharamurthy,
2005). We first measured the secondary structure of Hsp27 WT and S135F at the
concentration of 60µM based on the chaperone activity assay. Other concentrations,
100µM and 200µM were measured to see if the structure changed. The results showed
that the secondary structure was composed of a mixture between beta sheet and alpha
helix. It also showed that at different concentrations the secondary structure remained the
same meaning the structure of Hsp27 WT and S135F did not change. Interestingly,
S135F (Figure 4.4A) appeared to have more structure than the wild-type (Figure 4.4B) at
60µM or at any of the other concentrations measured.
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A

B

Figure 4.4 Green line represents the secondary structure of S135F at 60µM. Blue line
indicates the secondary structure at 100µM. Brown line indicates secondary structure
at 200 µM (A). Green line shows the secondary structure of Hsp27 WT at 60µM. Blue
line indicates the secondary structure at 100µM (B).
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Hsp27 is a heat shock protein, that is induced at different conditions at the cellular
level (e.g. temperature change). We did a gradient of different temperatures to simulate
heat shock: 5ºC, 25ºC, 37ºC, and 42ºC to study how these changes affect the secondary
structure. At a concentration of 100µM for mutation S135F (Figure 4.5A) and Hsp27 WT
(Figure 4.5B) mutation, interestingly their secondary structure changed. The structure of
Hsp27 that is changed under heat shock conditions, implies that it is one of the many
reasons why it is responsible for achieving and maintaining protein folding under stress
conditions.
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A

B

Figure 4.5 Blue line is the secondary structure of S135F at 5ºC. Light blue line indicates
at 25ºC. Green line indicates at 37ºC. Red line indicates at 42ºC (A). Blue line is the
secondary structure of Hsp27 WT at 5ºC. Light blue line indicates at 25ºC. Green line
indicates at 37ºC. Read line indicates at 42ºC (B).
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4.4 Size Characteristics of Hsp27 WT and S135F Chaperone
Dynamic light scattering as mentioned in chapter 2, is a method for measuring the
size distribution of any particle. We used this method to measure the overall size
distribution and the dispersity of Hsp27 WT and S135F in an aqueous environment at
different temperatures. Both samples as mentioned in chapter 3 were prepared by diluting
the protein to .5mg/ml in 1 mL of Buffer A (10mM Hepes, 5mM EDTA, 100mM NaCl). The
DLS machine read the sample twice for a total of 92 readings.
Hsp27 WT was placed inside the DLS machine where the first temperature was
set to read at 25ºC (Figure 4.6). We saw a size distribution of 18.13 d. nm with a
polydispersity index value of 0.143, meaning polydispersed sample. As the temperature
was increased to 37ºC, and 42ºC, the size distribution increased and became more
uniform. The temperature was then decreased to 5ºC, where interestingly the size
distribution was higher than 25ºC but still disordered.

Figure 4.6 Blue line indicates the size distribution of Hsp27 WT at
25ºC. Dark grey indicates the size distribution at 37ºC. Red line
indicates the size distribution at 42ºC. Light grey indicates the size
distribution at 5ºC.
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For the sample S135F the temperature was also changed, but this time as a
gradient (Figure 4.7). The first reading at 5ºC showed a diameter of 17.62, smaller than
the wild type chaperone Hsp27 at this temperature. However, based on the PDI it
measured 0.070 meaning the protein was monodispersed. It also showed that as the
temperature was increased the size distribution of the complexed increased significantly.
At 42ºC the PDI was 0.004, meaning that the sample was very uniformed in subunit size.
In comparison to the wild type it had more uniform symmetry because S135F had a PDI
of 0.004 versus the wild type was 0.054. Also, the diameter size for S135F was 24.83 d.
nm and Hsp27 WT was 20.86 d. nm. This is significant because it correlates with the
previous data from CD that S135F has more secondary structure than the Hsp27 WT.
The size distributions in Hsp27 under temperature changes appears to follow a subunit
exchange mechanism that results in a uniform protein.

Figure 4.7 Red line indicates the size distribution of mutation S135F at
5ºC. Blue line indicates the size distribution at 25ºC. Black line indicates
the size distribution at 37ºC. Green line indicates the size distribution at
42ºC.
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4.5 Micrographs of Hsp27 WT and S135F
Through negative staining the mutation S135F showed that it was composed of
small to large complexes (Figure 4.8). A reconstruction was intended but was not feasible
because the mutation S135F did not have symmetry, therefore making it difficult to
construct and image. This coincides with previous published work in that it is very difficult
to obtain a structure of the heat shock protein 27 and its mutations. However, based on
the DLS results, there is a possibility of incubating the protein sample at a temperature
where the protein is symmetrical.

Figure 4.8 Negative stain image of S135F at .1
mg/mL from TEM.
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4.6 Conclusion
Under regular and stress conditions, Hsp27 has the ability to change its
oligomerization that are involved in many cellular functions important for the stability of
the cells. To further investigate the properties of Hsp27 and its mutation S135F, 30%
ammonium sulfate was added as a pre-purification step, followed by two purification
columns, ion-exchange and size-exclusion chromatography. Based on the elution volume
from the size-exclusion column, Hsp27 and S135F eluted as large oligomeric complexes.
The chaperone activity was tested by using alpha-lactalbumin as a substrate for Hsp27
and S135F. It was observed that Hsp27 WT was able to prevent the substrate from
aggregating in the presence of DTT, whereas the mutation could not protect the substrate.
The mutation is located within the alpha-crystallin domain, which is already an unstable
domain. In addition, the mutation’s amino acid changes from a polar serine residue to
phenylalanine, which is hydrophobic, is a potential for more instability as the polarity of
serine may be relevant for substrate binding.
To further investigate the structure changes between the wild-type and the
mutation, circular dichroism and dynamic light scattering were performed. As previously
mentioned, the different concentrations did not play a factor in the structure change but
did show that S135F was more structured than the wild-type. This is possibly one of the
reasons S135F aggregates when bound to substrate. The structure of Hsp27 and S135F
were highly influenced by changes in temperature. This relates back to small heat shock
proteins being flexible in their structure under stress conditions. Negative stains were
prepared to visualize the structure of the chaperone, however, because their size
distribution changes rapidly, a single conformation cannot be isolated. There are other
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alternatives (eg. computational analyses), however, a complete structure of Hsp27 WT
and S135F remains unknown.
There are future directions that can help continue the biophysical analyses of
Hsp27 and S135F. Since the conformations of Hsp27 WT and S135F change under
different temperatures, it would be interesting to study the secondary structure changes
when bound to misfolded substrate. DLS results indicated a change in size distribution
that could be a way to isolate one confirmation of Hsp27 by incubating the protein at its
favorable temperature before adding it onto a grid. In addition, studying different sizes of
the wild-type and its mutation can help further understand their underlying mechanism
involved in CMT. Previous studies reported that the smaller complex of Hsp27 provides
better protection than bigger complexes, whereas others found no difference (Rogalla, et
al.) (Lelj-Garolla, 2006) (Panasenko, Seit Nebi, Bukach, Marston, & Gusev, 2002). We
found that the larger complex has chaperone properties as the wild-type was able to
protect alpha-lactalbumin from aggregating. For mutation S135F, it was reported that it is
a hyper-active chaperone in-vivo. Our results indicate that the large complexed S135 is
hyper-active in terms of binding to the substrate and not able to protect from aggregation.
The next step would be to study the chaperone activity of the smaller WT and S135F
complexes through phosphorylation using MAPKAPK2 enzyme. Failure to protect the
substrate could be one of the underlying causes of CMT.
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